Value added growth rate of pharmaceutical manufacturing vs Oncology novel active substance (NAS) launches (cumulative) in China
Value added growth rate of pharmaceutical manufacturing and Oncology novel active substance (NAS) launches (cumulative) in China, compared over time.
Change the pair
Compare different indicators
The series
Over time
China, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.
Value added growth rate of pharmaceutical manufacturing
Unit: % · 2 observations
View the underlying data
| Period | Type | Value |
|---|---|---|
| as of 31 Jul 2026 | Actual | 5.3% |
| July 2026 | Actual | 2.8% |
Oncology novel active substance (NAS) launches (cumulative)
Unit: count · 2 observations
Provenance
Where these numbers come from
Value added growth rate of pharmaceutical manufacturing
Year-on-year percentage change in the real value added of the pharmaceutical manufacturing industry among industrial sectors.
2 observations in China · source organisations: NBS China
Oncology novel active substance (NAS) launches (cumulative)
Total number of oncology novel active substances launched over a stated multi-year period.
2 observations in China · source organisations: IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring